Day 2 :
Institute for Health Metrics and Evaluation, USA
Keynote: The global burden of disease, injuries, and risk factors in 195 countries; Findings from the 2015 Global Burden of Disease, 1990-2015
Time : 9:30-10:05
Ali H Mokdad, PhD is the Director of Middle Eastern Initiatives and Professor of Global Health at the Institute for Health Metrics and Evaluation at the University of Washington. He started his career at the US Centers for Disease Control and Prevention (CDC) in 1990. He has published more than 350 articles and numerous reports and received several awards, including the Global Health Achievement Award for his work in Banda Aceh after the tsunami, the Department of Health and Human Services Honor Award for his work on flu monitoring, and the Shepard Award for outstanding scientific contribution to public health.
The Global Burden of Disease 2015 (GBD) is a systematic, scientific effort to quantify the comparative magnitude of health loss from all major diseases, injuries, and risk factors by age, sex, and population. We quantified a complete set of health loss metrics with uncertainty for 195 countries and territories, 11 of which—Brazil, China, India, Japan, Kenya, Mexico, Saudi Arabia, South Africa, Sweden, the United Kingdom, and the United States—were analyzed at the subnational level. In addition to the traditional health metrics such as disease and injury prevalence and incidence, death numbers and rates, GBD provides several metrics to report results on health loss related to specific diseases, injuries and risk factors: years of life lost due to premature mortality (YLLs), prevalence and prevalence rates for sequelae, years lived with disability (YLDs), and disability-adjusted life years (DALYs). We also report our findings by the Socio-demographic Index (SDI), developed as a summary measure of overall development based on estimates of lag dependent income per capita (LDI), average educational attainment over age 15 years, and total fertility rate (TFR). Life expectancy increased from 61.7 years (95% uncertainty interval 61.2-62.2) in 1980 to 71.8 years (71.2-72.4) in 2015. However, for some countries, life expectancy did not improve or declined. Non-communicable diseases (NCDs) deaths, increased by 14.4% to 39.8 million deaths (38.5‒41.3 million) in 2015 while age-standardized rates decreased by 13.0% (9.7‒16.2%). By contrast, both total deaths and age-standardized death rates due to communicable, maternal, neonatal, and nutritional conditions significantly declined between 2005 and 2015. From 1990 to 2015, four risks – unsafe sanitation, household air pollution, childhood underweight, and childhood stunting – saw a decrease of more than 30%; further, such reductions in risk exposure were similar among men and women. Our study showed that age-specific mortality has steadily improved over the last 35 years with progress made at a faster pace in the majority of countries with high SDI.
Transformational Health Industry Analyst, Frost & Sullivan, Malaysia
Shalani Andria, the Transformational Health Industry Analyst at Frost & Sullivan is a subject matter expert in Asia Pacific digital health market with thought leadership covering broad range of sectors within the digital health market including Video Telemedicine, Mobile Health, Remote Patient Monitoring, Home Care, Healthcare IT, Healthcare Big Data Analytics, Healthcare Interoperability and Internet of Medical Things. Shalani has extensive experience in strategy consulting, merger & acquisition, and public-private partnerships. She has advised top telehealth vendors, healthcare IT vendors, medical device vendors, hospital groups, and ministries on disruptive technologies, business model innovation, and sustainable ecosystem. She has been quoted in multiple industry magazines and journals.
Asia-Pacific (APAC) is moving from centralized to decentralized care-delivery models, with the need for efficient healthcare services outside the hospital. There has been an increase in demand for remote patient monitoring (RPM) devices by both healthcare providers and consumers in the home but adoption and adherence is low. The major roadblock is funding for high-tech devices and care management platforms. Some of the key challenges include:
• Absence of sustainable business models due to under-developed healthcare regulations and reimbursement mechanisms
• Lack of an ecosystem strategy that includes sustainable partnerships between telecommunication providers, healthcare providers, insurance companies, governments or others for home monitoring.
Failure to address these challenges result in inability to monetize home health monitoring solutions, although the market is packed with unexplored opportunities. This presentation will highlight some innovative business models that address these issues, and educate stakeholders on how and why the models are successful.